Measuring serum melatonin in epidemiologic studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 4, 2010, Pages 932-937

  Hsing, Ann W ^a   Meyer, Tamra E ^a   Niwa, Shelley ^b   Quraishi, Sabah M ^a   Chu, Lisa W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ARTICLE; BLOOD SAMPLING; CANCER EPIDEMIOLOGY; CANCER RESEARCH; ETHNICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; URINALYSIS;

CIRCADIAN RHYTHM; HUMANS; MALE; MELATONIN; NEOPLASMS; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77950823157     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0004     Document Type: Article

References (32)

1. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007;8:1065-1066
2. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan Collaborative Cohort Study. Am J Epidemiol 2006;164: 549-555
3. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology 2007;18:182-183 (Pubitemid 46005923)
4. Band PR, Le ND, Fang R, et al. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 1996; 143:137-143
5. Irvine D, Davies DM. British Airways flightdeck mortality study, 1950-1992. Aviat Space Environ Med 1999;70:548-555
6. Pukkala E, Aspholm R, Auvinen A, et al. Cancer incidence among 10, 211 airline pilots: a Nordic study. Aviat Space Environ Med 2003;74:699-706.
7. Kakizaki M, Inoue K, Kurlyama S, et al. Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 2008;99: 176-178 (Pubitemid 351920224)
8. SchemhammerES,LadenF,SpeizerFE,etal. RotatingnightshiftsandriskofbreastcancerinwomenparticipatingintheNurses'Health Study.JNatlCancerInst2001;93:1563-1568(Pubitemid32998486)
9. Schemhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology 2006;17:108-111 (Pubitemid 43755788)
10. Kakizaki M, Kuriyama S, Sone T, et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 2008;99: 1502-1505
11. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and metaanalysis. Eur J Cancer 2005;41:2023-2032 (Pubitemid 41557687)
12. SchemhammerES,LadenF,SpeizerFE,etal.Night- shiftworkandriskofcolorectalcancerintheNurses'HealthStudy.JNatlCancerInst2003; 95:825-828(Pubitemid36798430)
13. Lahti TA, Partonen T, Kyyrönen P, Kauppinen T, Pukkala E. Nighttime work predisposes to non-Hodgkin lymphoma. Int J Cancer 2008;123:2148-2151
14. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005;9:25-39.
15. Cardinali DP, Pevet P. Basic aspects of melatonin action. Sleep Med Rev 1998;2:175-190
16. Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res 2009;46: 245-247
17. ArendtJ,BojkowskiC,FraneyC,WrightJ,MarksV.Immunoassayof6- hydroxymelatoninsulfateinhumanplasmaandurine:abolitionoftheurinary24- hourrhythmwithatenolol.JClinEndocrinolMetab1985;60:1166-1173(Pubitemid15064777)
18. Earl CR, D'Occhio MJ, Kennaway DJ, Seamark RF. Serum melatonin profiles and endocrine responses of ewes exposed to a pulse of light late in the dark phase. Endocrinology 1985;117:226-230
19. VoultsiosA,KennawayDJ,DawsonD.Salivarymelatoninasacircadianphasemarker: validationandcomparison-plasmamelatonin.JBiolRhythms1997;12:457- 466(Pubitemid127478560)
20. LewyAJ,MarkeySP. Analysisofmelatonininhumanplasmabygaschromatographynegativechemicalionization massspectrometry.Science1978;201:741-743(Pubitemid9007678)
21. Wu AH, Wang R, Koh W-P, Stanczyk FZ, Lee H-P, Yu MC. Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 2008;29:1244-1248 (Pubitemid 351958705)
22. Thompson C, Franey C, Arendt J, Checkley SA. A comparison of melatonin secretion in depressed patients and normal subjects. Br J Psychiatry 1988;152:260-265
23. ShochatT,LuboshitzkyR,LavieP.Nocturnalmelatoninonsetisphaselocked- theprimarysleepgate.AmJPhysiol1997;273:R364-70.(Pubitemid27345593)
24. Benloucif S, Guico MJ, Reid KJ, Wolfe LF, L'Hermite-Balerlaux M, Zee PC. Stability of melatonin and temperature as circadian phase markers and their relation to sleep times in humans. J Biol Rhythms 2005;20:178-188 (Pubitemid 40389164)
25. Kumanov P, Tomova A, Isidori A, Nordio M. Altered melatonin secretion in hypogonadal men: clinical evidence. Int J Androl 2005:28: 234-240 (Pubitemid 41075942)
26. Robeva R, Kirilov G, Tomova A, Kumanov P. Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome. Andrologia 2006;38:216-220 (Pubitemid 44690785)
27. Chu LW, Zhu Y, Yu K, et al. Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis 2007;11:342-348
28. Chu LW, Li Q, Yu K, et al. Joint effects of circadian genes and serum androgens on prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Philadelphia (PA): Annual Meeting of the American Society of Human Genetics; 2008.
29. ZhuY,BrownHN,ZhangY,StevensRG,ZhengT.Period3structuralvariation: acircadianbiomarkerassociatedwithbreastcancerinyoungwomen. CancerEpidemiolBlomarkersPrev2005;14:268-270(Pubitemid40165313)
30. Zhu Y, Stevens R, Leaderer D, et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 2008;107:421-425 (Pubitemid 351172117)
31. Zhu Y, Leaderer D, Guss C, et al. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin 's lymphoma. Int J Cancer 2007;120:432-435 (Pubitemid 44956857)
32. Hoffman AE, Zheng T, Stevens RG, et al. Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res 2009;69: 3605-3613